Medicine and Dentistry
Uterine Cancer
100%
Premature Labor
97%
Neoplasm
91%
Ovarian Cancer
91%
Diseases
79%
Cesarean Section
76%
Pregnancy
68%
Malignant Neoplasm
60%
Gynecological Oncology
55%
Odds Ratio
53%
Cancer
47%
Cervical Cancer
43%
Pelvis
40%
Overall Survival
38%
Pre-Eclampsia
37%
Oncology
37%
Obstetrics
37%
Krukenberg Tumor
33%
Gestational Age
31%
Human Immunodeficiency Virus
31%
Recurrent Disease
31%
Infection
30%
Placenta
30%
Randomized Controlled Trial
30%
Colposcopy
29%
First Trimester Pregnancy
29%
Systematic Review
29%
Body Mass Index
28%
Wart Virus
27%
Meta-Analysis
27%
Health Care Cost
27%
Endometrium Carcinoma
27%
Oocyte
26%
Retrospective Cohort Study
25%
Fetus Growth
25%
Vaginal Delivery
25%
Amnion Fluid
24%
Endometriosis
24%
Bladder
24%
Logistic Regression Analysis
23%
Progression Free Survival
22%
Adolescence
22%
Radiation Therapy
22%
Vaginal Birth after Cesarean
21%
Cervix
21%
Surgery
21%
Metastatic Carcinoma
20%
Hysterectomy
20%
In Vitro Fertilisation
20%
Newborn Morbidity
20%
Clinician
20%
Neonate
20%
Small for Gestational Age
19%
Carcinoma
19%
Cytotechnology
19%
Intrauterine Growth Retardation
18%
Biopsy Technique
18%
Birth Weight
18%
Female Genital Tract Cancer
18%
Second Trimester Pregnancy
18%
Cervical Intraepithelial Neoplasia
16%
Bleeding
16%
Paclitaxel
16%
Diagnosis
16%
Counseling
16%
Clinical Trial
16%
Hazard Ratio
16%
Biological Marker
16%
Gynecology
15%
Intrapartum
15%
Assisted Reproductive Technology
15%
Programmed Cell Death
15%
Maternal Morbidity
15%
Prevalence
15%
Magnetic Resonance Imaging
15%
Intrauterine Device
15%
Cancer Cell
15%
Blastocyst
14%
In Vitro
14%
Papanicolaou Stain
14%
Endometrium
14%
Pelvic Organ Prolapse
14%
Umbilical Artery
14%
Cervical Cancer Screening
14%
Microsatellite Instability
14%
Prematurity
14%
Disease
13%
Quality of Life
13%
Nulliparous
13%
Stillbirth
13%
Twin Pregnancy
13%
Echography
13%
Cisplatin
13%
Diabetes
13%
Chorioamnionitis
13%
Pelvic Floor
13%
Urinary Tract Infection
12%
Fetus Monitoring
12%
Carcinosarcoma
12%
Fallopian Tube
12%
Keyphrases
Confidence Interval
91%
Endometrial Cancer
79%
Ovarian Cancer
69%
Tumor
58%
Preterm Birth
53%
Fetus
49%
Preterm Labor
46%
Cervical Cancer
43%
Cesarean Delivery
42%
Pregnant Women
39%
Preeclampsia
39%
Overall Survival
37%
Gynecologic Oncology Group
37%
NRG Oncology
35%
Placenta
34%
During Pregnancy
30%
Chemotherapy
30%
Risk Factors
30%
United States
29%
Obesity
28%
Endometriosis
28%
Randomized Controlled Trial
28%
Colposcopy
28%
Extravillous Trophoblast
28%
Adverse Pregnancy Outcomes
27%
Adjusted Odds Ratio
27%
Gestational Age
27%
High Risk
26%
Group Studies
26%
Odds Ratio
25%
Amniotic Fluid
25%
Meta-analysis
24%
Retrospective Cohort Study
23%
Apoptosis
23%
Body Mass Index
22%
Trophoblast
22%
Vaginal Birth
22%
Neonatal Morbidity
22%
Pregnancy Outcome
21%
Neonatal Outcome
21%
Infertility
21%
Spontaneous Preterm Birth (sPTB)
21%
Endometrial Carcinoma
21%
First Trimester
21%
Progression-free Survival
21%
AIDS/HIV
21%
Systematic Meta-analysis
20%
Ultrasound
20%
High-risk Human Papillomavirus (HR-HPV)
19%
Gynecologic Oncology
19%
Preterm Delivery
19%
Small-for-gestational Age
19%
Long-acting Reversible Contraception
19%
In Vitro Fertilization
19%
Hysterectomy
18%
Whole Genome
18%
Selective Intrauterine Growth Restriction (sIUGR)
18%
Cisplatin
18%
Uterus
18%
Obstetrics and Gynaecology
18%
Cervical Intraepithelial Neoplasia
17%
Hazard Ratio
17%
Contraceptives
17%
Recurrent Endometrial Cancer
17%
Microsatellite Instability-high (MSI-H)
17%
Paclitaxel
17%
Ovarian Cancer Patients
17%
Week of Gestation
17%
Cervical Carcinoma
16%
Induction of Labor
16%
Epithelial Ovarian Cancer
16%
Neonate
16%
Relative Risk
16%
Inflammation
16%
Twin-twin Transfusion Syndrome
16%
Pan-cancer Analysis
16%
Fetal Growth Restriction
16%
Ovarian Cancer Cells
16%
Cervical Cancer Screening
15%
Intrauterine Inflammation
15%
Obese Women
15%
Second Trimester
15%
Singleton Pregnancy
14%
Radiation Therapy
14%
Cervix
14%
Birth Weight
14%
Human Placenta
14%
Intra-amniotic Infection
14%
Adverse Neonatal Outcome
14%
Vaginal Delivery
14%
Endometrial Stromal Cells
14%
Randomized Trial
14%
Gynecologic Malignancies
14%
Gynecological Cancer
13%
Glucose Transporter 1 (GLUT1)
13%
Bevacizumab
13%
Gene Expression
13%
COVID-19
13%
Preterm Premature Rupture of Membranes (PPROM)
13%
Progesterone
13%